Literature DB >> 16570139

HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.

Chul-Woo Pyo1, Luke M Williams, Yuki Moore, Hironobu Hyodo, Shuying Sue Li, Lue Ping Zhao, Noriko Sageshima, Akiko Ishitani, Daniel E Geraghty.   

Abstract

Despite several studies that defined the polymorphism of the nonclassical human leukocyte antigen-E (HLA-E), HLA-F, and HLA-G genes, most polymorphisms thus far examined in correlative studies were derived from the coding sequences of these genes. In addition, some discrepancies and ambiguities in the available data have persisted in current databases. To expand the data available and to resolve some of the discrepant data, we have defined protocols that allow for the amplification of 6 to 7 kb of contiguous genomic sequence for each gene, including all of the coding and intron sequences, approximately 2 kb of 5' flanking promoter sequence, and 1 kb of 3' flanking sequence. Using long-range polymerase chain reaction (PCR) protocols, generating either one or two PCR products depending on the locus, amplified genomic DNA was directly sequenced to completion using a set of about 30 primers over each locus to yield contiguous sequence data from both strands. Using this approach, we sequenced 33 genomic DNAs, from Asian, African American, and Caucasian samples. The results of this analysis confirmed several previously reported coding sequence variants, identified several new allelic variants, and also defined extensive variation in intron and flanking sequences. It was possible to construct haplotype maps and to identify tagging single nucleotide polymorphisms that can be used to detect the composite variation spanning all three genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570139     DOI: 10.1007/s00251-005-0076-z

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  49 in total

1.  Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.

Authors:  Akiko Ishitani; Noriko Sageshima; Ni Lee; Natalia Dorofeeva; Katsuhiko Hatake; Hans Marquardt; Daniel E Geraghty
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 2.  Data acquisition, data storage, and data presentation in a modern genetics laboratory.

Authors:  D E Geraghty; S Fortelny; B Guthrie; M Irving; H Pham; R Wang; R Daza; B Nelson; J Stonehocker; L Williams; Q Vu
Journal:  Rev Immunogenet       Date:  2000

3.  The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.

Authors:  Suraksha Agrawal; Manoj Kumar Pandey
Journal:  J Hematother Stem Cell Res       Date:  2003-12

4.  How useful is the fine-scale mapping of complex trait linkage peaks? Evaluating the impact of additional microsatellite genotyping on the posterior probability of linkage.

Authors:  Steven Wiltshire; Andrew P Morris; Mark I McCarthy; Lon R Cardon
Journal:  Genet Epidemiol       Date:  2005-01       Impact factor: 2.135

5.  Linkage disequilibrium grouping of single nucleotide polymorphisms (SNPs) reflecting haplotype phylogeny for efficient selection of tag SNPs.

Authors:  Fumihiko Takeuchi; Kazuyuki Yanai; Toshiyuki Morii; Yuji Ishinaga; Keiko Taniguchi-Yanai; Shinobu Nagano; Norihiro Kato
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

6.  The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B.

Authors:  S J Gobin; V Keijsers; M van Zutphen; P J van den Elsen
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

7.  Consed: a graphical tool for sequence finishing.

Authors:  D Gordon; C Abajian; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

Review 8.  Placental expression of HLA class I genes.

Authors:  P Le Bouteiller; A M Rodriguez; V Mallet; M Girr; T Guillaudeux; F Lenfant
Journal:  Am J Reprod Immunol       Date:  1996-03       Impact factor: 3.886

9.  A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

Authors:  T Fujii; A Ishitani; D E Geraghty
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Complete MHC haplotype sequencing for common disease gene mapping.

Authors:  C Andrew Stewart; Roger Horton; Richard J N Allcock; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Ian Dunham; Simon Forbes; Karen Halls; Joanna M M Howson; Sean J Humphray; Sarah Hunt; Andrew J Mungall; Kazutoyo Osoegawa; Sophie Palmer; Anne N Roberts; Jane Rogers; Sarah Sims; Yu Wang; Laurens G Wilming; John F Elliott; Pieter J de Jong; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  Genome Res       Date:  2004-05-12       Impact factor: 9.043

View more
  14 in total

Review 1.  Nomenclature for factors of the HLA system, 2010.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; M Fernández-Viña; D E Geraghty; R Holdsworth; C K Hurley; M Lau; K W Lee; B Mach; M Maiers; W R Mayr; C R Müller; P Parham; E W Petersdorf; T Sasazuki; J L Strominger; A Svejgaard; P I Terasaki; J M Tiercy; J Trowsdale
Journal:  Tissue Antigens       Date:  2010-04

2.  Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide.

Authors:  Nora E Renthal; Paula A Guidry; Sharmila Shanmuganad; William Renthal; Iwona Stroynowski
Journal:  Immunogenetics       Date:  2010-10-22       Impact factor: 2.846

3.  Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma.

Authors:  Jian Zhang; Lelin Pan; Luyan Chen; Xiaowen Feng; Lin Zhou; Shusen Zheng
Journal:  Immunogenetics       Date:  2011-10-21       Impact factor: 2.846

4.  HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

5.  HLA-F complex without peptide binds to MHC class I protein in the open conformer form.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

6.  Characterisation of major histocompatibility complex class I genes at the fetal-maternal interface of marsupials.

Authors:  Ina Buentjen; Barbara Drews; Stephen R Frankenberg; Thomas B Hildebrandt; Marilyn B Renfree; Brandon R Menzies
Journal:  Immunogenetics       Date:  2015-05-09       Impact factor: 2.846

7.  Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

Authors:  Chul-Woo Pyo; Lisbeth A Guethlein; Quyen Vu; Ruihan Wang; Laurent Abi-Rached; Paul J Norman; Steven G E Marsh; Jeffrey S Miller; Peter Parham; Daniel E Geraghty
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

8.  Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.

Authors:  Viviana Romero; Charles E Larsen; Jonathan S Duke-Cohan; Edward A Fox; Tatiana Romero; Olga P Clavijo; Dolores A Fici; Zaheed Husain; Ingrid Almeciga; Dennis R Alford; Zuheir L Awdeh; Joaquin Zuñiga; Lama El-Dahdah; Chester A Alper; Edmond J Yunis
Journal:  BMC Genet       Date:  2007-04-12       Impact factor: 2.797

9.  Recombinant structures expand and contract inter and intragenic diversification at the KIR locus.

Authors:  Chul-Woo Pyo; Ruihan Wang; Quyen Vu; Nezih Cereb; Soo Young Yang; Fuh-Mei Duh; Steven Wolinsky; Maureen P Martin; Mary Carrington; Daniel E Geraghty
Journal:  BMC Genomics       Date:  2013-02-08       Impact factor: 3.969

10.  The Mhc class II of the Black grouse (Tetrao tetrix) consists of low numbers of B and Y genes with variable diversity and expression.

Authors:  Tanja Strand; Helena Westerdahl; Jacob Höglund; Rauno V Alatalo; Heli Siitari
Journal:  Immunogenetics       Date:  2007-07-25       Impact factor: 3.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.